BioSpace News Archive

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a Research & Development Day on June 1, 2023, beginning at 9 a.m. ET in New York City.

Ludwig Enterprises, Inc, (OTC PINK:LUDG) (Ludwig - The Genomics Language Company) is proud to announce that its flagship nutraceutical, NuGenea launch will be forthcoming.

Akoya Biosciences, Inc. announced the launch of PhenoCode™ Discovery Panels, which simplify spatial biology workflows performed on the company’s PhenoCycler-Fusion platform, at the American Association for Cancer Research Annual Meeting being held in Orlando, Florida, April 14-19, 2023.

Myriad Genetics, Inc. announced the planned launch of a new hereditary cancer assessment program that combines diagnostic imaging, genetic risk assessment utilizing MyRisk® with RiskScore® and patient education.

PDS Biotechnology Corporation announced it will host a Key Opinion Leader (KOL) Roundtable on Interleukin-12 (IL-12) for analysts, investors and the scientific community from 8:00 to 9:00 AM, ET on April 21, 2023.

Freeline Therapeutics Holdings plc announced that its Chief Executive Officer Michael Parini will present at the 22nd Annual Needham Virtual Healthcare Conference being held on April 17-20, 2023.

Viridian Therapeutics, Inc. today announced the appointment of Tony Casciano to the role of Chief Commercial Officer (CCO).

Cue Biopharma, Inc. announced today the appointment of industry veteran Patrick Verheyen to its board of directors (BOD).

Cogent Biosciences, Inc. today announced its participation in the following upcoming virtual investor conferences.

Pliant Therapeutics, Inc. today announced that Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a fireside chat as part of the 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19, 2023, at 3:45 p.m. Eastern Time.